Tuberculosis, both in man and experimental animals, can manifest itself in almost any degree of severity and progression, from a relatively acute and progressive generalized infection to one in which the infection remains localized and apparently stable. The latter type of disease is a manifestation of partial immunity, in which not all tubercle bacilli are destroyed and in which the surviving bacilli remain in equilibrium with the host, often for long periods. Analysis of the resulting host-parasite equilibrium is pertinent to our understanding of the type of immune process frequently seen in tuberculosis, the state of bacilli in a stable infection, the viability of bacilli in such an infection and the choice of treatment for the chronic type of infection, which even in this successful era of chemotherapy is the more difficult type of infection to treat.
In mice, chronic tuberculosis can readily be produced as a predominantly pulmonary infection either by giving small doses of tubercle bacilli (Hart & Rees 1950 , 1960 , or by challenging with larger doses of bacilli following vaccination with BCG (Sever & Youmans 1957) . The resulting infections are a manifestation of partial immunity, either to the primary infection or to the vaccination. Under both conditions of infection the majority of the mice remain alive for many weeks, appear healthy and gain weight, yet they have obvious pulmonary lesions in which there are many acid-fast bacilli which grow readily on culture. It appears a stable pulmonary disease with a steady viable bacillary population in the lungs, although under certain stresses this infection can break down and the bacilli freely multiply. For example, when such mice are given cortisone, the infection spreads and these animals may die within twenty days with a great increase in the number of bacilli in the lungs (Hart & Rees 1950) . Where the number of viable tubercle bacilli have been counted in the lungs of the mice during the chronic infection, the results suggest that the bacilli remain alive but do not divide -'a static equilibrium' -yet evidence based on viable counts alone does not exclude a 'dynamic equilibrium'. This equilibrium was therefore analysed further by following in parallel the viable and the total (stainable) bacillary populations in lung homogenates from mice with untreated chronic tuberculosis (Hart & Rees 1960 ). The total counts from the lungs remained steady and were similar to the viable counts from day 60 to day 138. The results indicated that unless dead organisms were being removed from the lungs or that their acid-fastness was being lost, the bacillary population was viable and not multiplying.
In order to see what happened to dead bacilli in the lungs of such mice, a group of animals was given a powerful bactericidal combination of drugs. By disturbing the host-parasite equilibrium in this way it was hoped to follow the fate of the killed bacilli in the lungs. A combination of isoniazid and pyrazinamide was chosen since, from the work of McCune et al. (1956) , this appears to be the most powerful bactericidal combination for mice. A composite picture of the results obtained (Rees & Hart 1961 ) are shown in Fig 1. Although the viable counts fell steeply throughout the treatment period, total counts remained high and fell only slowly, after three weeks' treatment, below the total counts of the untreated mice. These results indicated that a high proportion of the dead bacilli (killed by treatment with isoniazid and pyrazinamide) were not removed from the lungs and retained their acid-fastness. It is concluded, therefore, that in chronic murine tuberculosis, the bacilli are in a static or resting phase, rather than in a 'dynamic equilibrium' between multiplication and destruction.
It is likely that in man there may be similar situations either in the lungs or in other organs (1956) with p-aminosalicylic acid and of Hart & Rees (1960) with macrocyclon, that these bacteriostatic drugs have little or no effect against chronic infection in mice. Yet both these drugs, in particular macrocyclon, have considerable activity against an acute infection in micewhere the bacterial population is a freely multiplying one. The contrast between the effectiveness of macrocyclon and p-aminosalicylic acid in vivo against an acute infection, and their ineffectiveness against a chronic infection, is almost certainly a reflection of similar contrasts between the action in vitro of other bacteriostatic drugs on multiplying and nonmultiplying bacilli (Singh & Mitchison 1955 , Hobby & Lenert 1957 . McCune et al. (1956) also found little or no evidence of drug resistance during the treatment of chronic murine infections. This is probably because resistant variants could not grow out from a predominantly resting population of bacilli. The dual counting technique, including the counting of total numbers of stained bacilli in the lungs, shows that even when a very high proportion of the bacilli are killed by chemotherapy they can remain in a stainable form in situ for many weeks. From other exoerimental work this finding is not unexpected since it is known that dead pathogenic mycobacteria injected into animals remain in situ in a stainable state for very long periods. In man, in contrast with mice, the pulmonary lesions remain open and killed bacilli are readily shed into the bronchi. Also in man, stainable but culture-negative bacilli are not uncommonly found, particularly after chemotherapy, in the closed 'round lesions' in the lungs and other isolated sites in the body. It has been suggested that these organisms are not really dead but only modified by chemotherapy and unable to grow in the usual culture media. Our experimental findings are against this hypothesis because they clearly show that acid-fastness can persist in vivo long after the organism is dead. This work has been carried out in collaboration with my colleague Dr P D'Arcy Hart.
Anonymous Mycobacteria as a Cause of Phthisis by J Marks MD MRCP (Cardiff)
The diagnosis of phthisis by bacteriological methods dates from 1882 but it was not until some decades later that the cultivation of tubercle bacilli became widely practised. From that time, reports began to appear in the literature of unusual mycobacteria isolated from apparently typical cases of tuberculosis. Although most of the early observations were limited to one or two cases, several authors recognized and discussed fully the significance of these mycobacteria (e.g. Beaven & Bayne-Jones 1931); but little general interest was aroused in either the organisms or the disease with which they were associated. That situation has now changed. The reports have multiplied and the subject has become familiar to all interested in chest disease. Two factors especially have been responsible for this development. First, the introduction of chemotherapy for tuberculosis not only led to a demand for many more cultures for the purpose of sensitivity tests,
